Celecoxib vs. diclofenac plus omeprazole for OA or RA treatment with lesser GI risk
Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trialLancet. 2010 Jul 17;376(9736):173-9. Epub 2010 Jun 16
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
4484 cardiovascularly healthy patients with a clinical diagnosis of osteoarthritis or rheumatoid arthritis were randomized to be treated with either selective cox-2 inhibitor NSAID (celecoxib) or a combination of non-selective NSAID (diclofenac) and a proton pump inhibitor (omeprazole) for at least 6 months. After 6 months of treatment observation period, the rate of clinically significant GI even...
Join the Conversation
Please Login or Join to leave comments.